These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 1720996)
21. Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. Johnson M; Stone DM; Hanson GR; Gibb JW Eur J Pharmacol; 1987 Mar; 135(2):231-4. PubMed ID: 2884120 [TBL] [Abstract][Full Text] [Related]
22. Compensatory activation of substance P biosynthesis by L-dihydroxyphenylalanine in striatonigral neurons of neonatal dopaminergic denervated rats. Sivam SP; Krause JE J Pharmacol Exp Ther; 1990 Aug; 254(2):433-9. PubMed ID: 1696630 [TBL] [Abstract][Full Text] [Related]
23. Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonists. Bannon MJ; Elliott PJ; Bunney EB Brain Res; 1987 Dec; 427(1):31-7. PubMed ID: 2448008 [TBL] [Abstract][Full Text] [Related]
24. Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult rats. Takeuchi Y; Sawada T; Blunt S; Jenner P; Marsden CD Brain Res; 1991 Oct; 562(2):301-5. PubMed ID: 1685345 [TBL] [Abstract][Full Text] [Related]
25. Tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA. Sivam SP; Krause JE J Neurochem; 1992 Dec; 59(6):2278-84. PubMed ID: 1279124 [TBL] [Abstract][Full Text] [Related]
26. Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents. Campbell K; Wictorin K; Björklund A Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10489-93. PubMed ID: 1438238 [TBL] [Abstract][Full Text] [Related]
27. Suppression of serotonin hyperinnervation does not alter the dysregulatory influences of dopamine depletion on striatal neuropeptide gene expression in rodent neonates. Basura GJ; Walker PD Neurosci Lett; 1999 Oct; 274(1):9-12. PubMed ID: 10530507 [TBL] [Abstract][Full Text] [Related]
28. Brain-derived neurotrophic factor enhances striatal neuropeptide expression in both the intact and the dopamine-depleted rat striatum. Sauer H; Campbell K; Wiegand SJ; Lindsay RM; Björklund A Neuroreport; 1994 Jan; 5(5):609-12. PubMed ID: 8025254 [TBL] [Abstract][Full Text] [Related]
29. Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra. Cruz CJ; Beckstead RM Neuroscience; 1989; 30(2):331-8. PubMed ID: 2473415 [TBL] [Abstract][Full Text] [Related]
30. Dopamine-dependent postnatal development of enkephalin and tachykinin neurons of rat basal ganglia. Sivam SP; Krause JE; Breese GR; Hong JS J Neurochem; 1991 May; 56(5):1499-508. PubMed ID: 1707436 [TBL] [Abstract][Full Text] [Related]
31. Differential regulation of preprotachykinin-A mRNA expression in striatum by excitation of hippocampal neurons. Brené S; Lindefors N; Herrera-Marschitz M; Persson H Eur J Neurosci; 1993 Jul; 5(7):839-45. PubMed ID: 8281296 [TBL] [Abstract][Full Text] [Related]
32. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior. Sivam SP Brain Res; 1989 Oct; 500(1-2):119-30. PubMed ID: 2481560 [TBL] [Abstract][Full Text] [Related]
33. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons. Bannon MJ; Lee JM; Giraud P; Young A; Affolter HU; Bonner TI J Biol Chem; 1986 May; 261(15):6640-2. PubMed ID: 2422168 [TBL] [Abstract][Full Text] [Related]
34. Midbrain dopamine neurons regulate preprotachykinin-A mRNA expression in the rat forebrain during development. Brené S; Lindefors N; Persson H Brain Res Mol Brain Res; 1992 Jun; 14(1-2):13-9. PubMed ID: 1323010 [TBL] [Abstract][Full Text] [Related]
35. Changes in steady-state levels of tryptophan hydroxylase protein in adult rat brain after neonatal 6-hydroxydopamine lesion. Raison S; Weissmann D; Rousset C; Pujol JF; Descarries L Neuroscience; 1995 Jul; 67(2):463-75. PubMed ID: 7675179 [TBL] [Abstract][Full Text] [Related]
37. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei. Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949 [TBL] [Abstract][Full Text] [Related]
38. Differential regional effects of long-term L-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned rat. Salin P; Dziewczapolski G; Gershanik OS; Nieoullon A; Raisman-Vozari R Brain Res Mol Brain Res; 1997 Jul; 47(1-2):311-21. PubMed ID: 9221930 [TBL] [Abstract][Full Text] [Related]
39. Nigrostriatal dopamine neurons receive substance P-ergic inputs in the substantia nigra: application of the immunoelectron microscopic mirror technique to fluorescent double-staining for transmitter-specific projections. Kawai Y; Takagi H; Kumoi Y; Shiosaka S; Tohyama M Brain Res; 1987 Jan; 401(2):371-6. PubMed ID: 2434194 [TBL] [Abstract][Full Text] [Related]
40. Tachykinins in the rat substantia nigra: effects of selective dopamine receptor antagonists. Oblin A; Zivkovic B Fundam Clin Pharmacol; 1991; 5(2):129-38. PubMed ID: 1712746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]